Tiare 90 Tablet is used to reduce the risk of cardiovascular events, myocardial infarction, and stroke in adults with acute coronary syndromes (ACS) or a history of myocardial infarction. It is also used to reduce the risk of stent thrombosis in patients who have undergone percutaneous coronary intervention (PCI).
It contains ticagrelor 90mg, a reversible P2Y12 receptor antagonist. Take it as prescribed, usually with low-dose aspirin. Do not stop this medicine without your doctor's advice, as sudden discontinuation significantly increases clot risk. Unlike clopidogrel, ticagrelor is not a prodrug and does not require metabolic activation, providing a more predictable antiplatelet effect.
Attending all cardiology follow-up appointments, reporting any unusual bleeding promptly, and informing all healthcare providers before any procedure or surgery all support safe management alongside this medicine.
Before taking this medicine, tell your doctor about any bleeding disorders, history of intracranial haemorrhage, severe liver disease, or other antiplatelet or anticoagulant medicines. Breathlessness (dyspnoea) is a known side effect that is not due to bronchospasm; inform your doctor but do not stop the medicine without advice. It is not suitable during pregnancy.


































































